According to the CDC, Clostridium difficile is now the most common microbial healthcare associated infection (HAI), with annual healthcare costs exceeding $4.8 billion. Approximately 15,000 deaths are attributable to C. difficile infection each year in the US.
C. difficile is a common but expensive to treat infection
The Value of Simplexa® C. difficile Universal Direct Kit
Empower clinicians to quickly treat and isolate patients.
Rapid results and high-throughput
Simplexa® C. difficile Universal Direct assay for up to 94 patient samples per run with results in about 1 hour.
Delivers diagnostic confidence
Greater than 99% positive agreement.
How the Simplexa® C. difficile Universal Direct Kit works
Simple sample prepartion with no extaction step required.
One target, two consumables
Select the kit that fits your workflow needs. The 96-well Universal Disc allows for higher volume, batched runs.
To be used on the LIAISON® MDX Instrument
The LIAISON® MDX is an innovative and powerful real-time PCR instrument with two consumable disc options: the 8-well Direct Amplification Disc and the 96-well Universal Disc for higher volume testing.
Supported by an expanding menu of molecular assays, the system provides easy-to-understand results with the ability to check amplification curves after a run. All of this in a compact footprint measuring only 12″ by 8″ by 12″ so that it can fit into laboratories of any size.
Simplexa® C. difficile Universal Direct Kit ordering info
Simplexa® C. difficile Universal Direct Kit